A Genetic Variant of the Atrial Natriuretic Peptide Gene Is Associated With Cardiometabolic Protection in the General Community

We sought to define the cardiometabolic phenotype associated with rs5068, a genetic variant of the atrial natriuretic peptide (ANP) gene. The ANP and B-type natriuretic peptide play an important role in cardiorenal homeostasis but also exert metabolic actions. We genotyped 1,608 randomly selected re...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 58; no. 6; pp. 629 - 636
Main Authors Cannone, Valentina, Boerrigter, Guido, Cataliotti, Alessandro, Costello-Boerrigter, Lisa C., Olson, Timothy M., McKie, Paul M., Heublein, Denise M., Lahr, Brian D., Bailey, Kent R., Averna, Maurizio, Redfield, Margaret M., Rodeheffer, Richard J., Burnett, John C.
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 02.08.2011
Elsevier
Elsevier Limited
Subjects
Online AccessGet full text
ISSN0735-1097
1558-3597
1558-3597
DOI10.1016/j.jacc.2011.05.011

Cover

Loading…
Abstract We sought to define the cardiometabolic phenotype associated with rs5068, a genetic variant of the atrial natriuretic peptide (ANP) gene. The ANP and B-type natriuretic peptide play an important role in cardiorenal homeostasis but also exert metabolic actions. We genotyped 1,608 randomly selected residents from Olmsted County, Minnesota. Subjects were well-characterized. Genotype frequencies were: AA 89.9%, AG 9.7%, and GG 0.4%; all subsequent analyses were AA versus AG+GG. The G allele was associated with increased plasma levels of N-terminal pro-atrial natriuretic peptide (p = 0.002), after adjustment for age and sex. The minor allele was also associated with lower body mass index (BMI) (p = 0.006), prevalence of obesity (p = 0.002), waist circumference (p = 0.021), lower levels of C-reactive protein (p = 0.027), and higher values of high-density lipoprotein cholesterol (p = 0.019). The AG+GG group had a lower systolic blood pressure (p = 0.011) and lower prevalence of myocardial infarction (p = 0.042). The minor allele was associated with a lower prevalence of metabolic syndrome (p = 0.025). The associations between the G allele and high-density lipoprotein cholesterol, C-reactive protein values, myocardial infarction, and metabolic syndrome were not significant, after adjusting for BMI; the associations with systolic blood pressure, BMI, obesity, and waist circumference remained significant even after adjusting for N-terminal pro-atrial natriuretic peptide. In a random sample of the general U.S. population, the minor allele of rs5068 is associated with a favorable cardiometabolic profile. These findings suggest that rs5068 or genetic loci in linkage disequilibrium might affect susceptibility for cardiometabolic diseases and support the possible protective role of natriuretic peptides by their favorable effects on metabolic function. Replication studies are needed to confirm our findings.
AbstractList We sought to define the cardiometabolic phenotype associated with rs5068, a genetic variant of the atrial natriuretic peptide (ANP) gene. The ANP and B-type natriuretic peptide play an important role in cardiorenal homeostasis but also exert metabolic actions. We genotyped 1,608 randomly selected residents from Olmsted County, Minnesota. Subjects were well-characterized. Genotype frequencies were: AA 89.9%, AG 9.7%, and GG 0.4%; all subsequent analyses were AA versus AG+GG. The G allele was associated with increased plasma levels of N-terminal pro-atrial natriuretic peptide (p = 0.002), after adjustment for age and sex. The minor allele was also associated with lower body mass index (BMI) (p = 0.006), prevalence of obesity (p = 0.002), waist circumference (p = 0.021), lower levels of C-reactive protein (p = 0.027), and higher values of high-density lipoprotein cholesterol (p = 0.019). The AG+GG group had a lower systolic blood pressure (p = 0.011) and lower prevalence of myocardial infarction (p = 0.042). The minor allele was associated with a lower prevalence of metabolic syndrome (p = 0.025). The associations between the G allele and high-density lipoprotein cholesterol, C-reactive protein values, myocardial infarction, and metabolic syndrome were not significant, after adjusting for BMI; the associations with systolic blood pressure, BMI, obesity, and waist circumference remained significant even after adjusting for N-terminal pro-atrial natriuretic peptide. In a random sample of the general U.S. population, the minor allele of rs5068 is associated with a favorable cardiometabolic profile. These findings suggest that rs5068 or genetic loci in linkage disequilibrium might affect susceptibility for cardiometabolic diseases and support the possible protective role of natriuretic peptides by their favorable effects on metabolic function. Replication studies are needed to confirm our findings.
OBJECTIVES: We sought to define the cardiometabolic phenotype associated with rs5068, a genetic variant of the atrial natriuretic peptide (ANP) gene. BACKGROUND: The ANP and B-type natriuretic peptide play an important role in cardiorenal homeostasis but also exert metabolic actions. METHODS: We genotyped 1,608 randomly selected residents from Olmsted County, Minnesota. Subjects were well-characterized. RESULTS: Genotype frequencies were: AA 89.9%, AG 9.7%, and GG 0.4%; all subsequent analyses were AA versus AG+GG. The G allele was associated with increased plasma levels of N-terminal pro-atrial natriuretic peptide (p = 0.002), after adjustment for age and sex. The minor allele was also associated with lower body mass index (BMI) (p = 0.006), prevalence of obesity (p = 0.002), waist circumference (p = 0.021), lower levels of C-reactive protein (p = 0.027), and higher values of high-density lipoprotein cholesterol (p = 0.019). The AG+GG group had a lower systolic blood pressure (p = 0.011) and lower prevalence of myocardial infarction (p = 0.042). The minor allele was associated with a lower prevalence of metabolic syndrome (p = 0.025). The associations between the G allele and high-density lipoprotein cholesterol, C-reactive protein values, myocardial infarction, and metabolic syndrome were not significant, after adjusting for BMI; the associations with systolic blood pressure, BMI, obesity, and waist circumference remained significant even after adjusting for N-terminal pro-atrial natriuretic peptide. CONCLUSIONS: In a random sample of the general U.S. population, the minor allele of rs5068 is associated with a favorable cardiometabolic profile. These findings suggest that rs5068 or genetic loci in linkage disequilibrium might affect susceptibility for cardiometabolic diseases and support the possible protective role of natriuretic peptides by their favorable effects on metabolic function. Replication studies are needed to confirm our findings.
We sought to define the cardiometabolic phenotype associated with rs5068, a genetic variant of the atrial natriuretic peptide (ANP) gene.OBJECTIVESWe sought to define the cardiometabolic phenotype associated with rs5068, a genetic variant of the atrial natriuretic peptide (ANP) gene.The ANP and B-type natriuretic peptide play an important role in cardiorenal homeostasis but also exert metabolic actions.BACKGROUNDThe ANP and B-type natriuretic peptide play an important role in cardiorenal homeostasis but also exert metabolic actions.We genotyped 1,608 randomly selected residents from Olmsted County, Minnesota. Subjects were well-characterized.METHODSWe genotyped 1,608 randomly selected residents from Olmsted County, Minnesota. Subjects were well-characterized.Genotype frequencies were: AA 89.9%, AG 9.7%, and GG 0.4%; all subsequent analyses were AA versus AG+GG. The G allele was associated with increased plasma levels of N-terminal pro-atrial natriuretic peptide (p = 0.002), after adjustment for age and sex. The minor allele was also associated with lower body mass index (BMI) (p = 0.006), prevalence of obesity (p = 0.002), waist circumference (p = 0.021), lower levels of C-reactive protein (p = 0.027), and higher values of high-density lipoprotein cholesterol (p = 0.019). The AG+GG group had a lower systolic blood pressure (p = 0.011) and lower prevalence of myocardial infarction (p = 0.042). The minor allele was associated with a lower prevalence of metabolic syndrome (p = 0.025). The associations between the G allele and high-density lipoprotein cholesterol, C-reactive protein values, myocardial infarction, and metabolic syndrome were not significant, after adjusting for BMI; the associations with systolic blood pressure, BMI, obesity, and waist circumference remained significant even after adjusting for N-terminal pro-atrial natriuretic peptide.RESULTSGenotype frequencies were: AA 89.9%, AG 9.7%, and GG 0.4%; all subsequent analyses were AA versus AG+GG. The G allele was associated with increased plasma levels of N-terminal pro-atrial natriuretic peptide (p = 0.002), after adjustment for age and sex. The minor allele was also associated with lower body mass index (BMI) (p = 0.006), prevalence of obesity (p = 0.002), waist circumference (p = 0.021), lower levels of C-reactive protein (p = 0.027), and higher values of high-density lipoprotein cholesterol (p = 0.019). The AG+GG group had a lower systolic blood pressure (p = 0.011) and lower prevalence of myocardial infarction (p = 0.042). The minor allele was associated with a lower prevalence of metabolic syndrome (p = 0.025). The associations between the G allele and high-density lipoprotein cholesterol, C-reactive protein values, myocardial infarction, and metabolic syndrome were not significant, after adjusting for BMI; the associations with systolic blood pressure, BMI, obesity, and waist circumference remained significant even after adjusting for N-terminal pro-atrial natriuretic peptide.In a random sample of the general U.S. population, the minor allele of rs5068 is associated with a favorable cardiometabolic profile. These findings suggest that rs5068 or genetic loci in linkage disequilibrium might affect susceptibility for cardiometabolic diseases and support the possible protective role of natriuretic peptides by their favorable effects on metabolic function. Replication studies are needed to confirm our findings.CONCLUSIONSIn a random sample of the general U.S. population, the minor allele of rs5068 is associated with a favorable cardiometabolic profile. These findings suggest that rs5068 or genetic loci in linkage disequilibrium might affect susceptibility for cardiometabolic diseases and support the possible protective role of natriuretic peptides by their favorable effects on metabolic function. Replication studies are needed to confirm our findings.
Author Lahr, Brian D.
Olson, Timothy M.
Heublein, Denise M.
McKie, Paul M.
Bailey, Kent R.
Costello-Boerrigter, Lisa C.
Burnett, John C.
Cannone, Valentina
Averna, Maurizio
Boerrigter, Guido
Cataliotti, Alessandro
Rodeheffer, Richard J.
Redfield, Margaret M.
AuthorAffiliation Division of Biostatistics, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, MN, USA
Department of Clinical Medicine and Emerging Diseases, University of Palermo, Palermo, Italy
Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, MN, USA
Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, MN, USA
Cardiovascular Genetics Research Laboratory, Divisions of Cardiovascular Diseases and Pediatric Cardiology, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, MN, USA
AuthorAffiliation_xml – name: Department of Clinical Medicine and Emerging Diseases, University of Palermo, Palermo, Italy
– name: Cardiovascular Genetics Research Laboratory, Divisions of Cardiovascular Diseases and Pediatric Cardiology, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, MN, USA
– name: Division of Biostatistics, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, MN, USA
– name: Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, MN, USA
– name: Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, MN, USA
Author_xml – sequence: 1
  givenname: Valentina
  surname: Cannone
  fullname: Cannone, Valentina
  email: cannone.valentina@mayo.edu
  organization: Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minnesota
– sequence: 2
  givenname: Guido
  surname: Boerrigter
  fullname: Boerrigter, Guido
  organization: Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minnesota
– sequence: 3
  givenname: Alessandro
  surname: Cataliotti
  fullname: Cataliotti, Alessandro
  organization: Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minnesota
– sequence: 4
  givenname: Lisa C.
  surname: Costello-Boerrigter
  fullname: Costello-Boerrigter, Lisa C.
  organization: Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minnesota
– sequence: 5
  givenname: Timothy M.
  surname: Olson
  fullname: Olson, Timothy M.
  organization: Cardiovascular Genetics Research Laboratory, Divisions of Cardiovascular Diseases and Pediatric Cardiology, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minnesota
– sequence: 6
  givenname: Paul M.
  surname: McKie
  fullname: McKie, Paul M.
  organization: Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minnesota
– sequence: 7
  givenname: Denise M.
  surname: Heublein
  fullname: Heublein, Denise M.
  organization: Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minnesota
– sequence: 8
  givenname: Brian D.
  surname: Lahr
  fullname: Lahr, Brian D.
  organization: Division of Biostatistics, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minnesota
– sequence: 9
  givenname: Kent R.
  surname: Bailey
  fullname: Bailey, Kent R.
  organization: Division of Biostatistics, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minnesota
– sequence: 10
  givenname: Maurizio
  surname: Averna
  fullname: Averna, Maurizio
  organization: Department of Clinical Medicine and Emerging Diseases, University of Palermo, Palermo, Italy
– sequence: 11
  givenname: Margaret M.
  surname: Redfield
  fullname: Redfield, Margaret M.
  organization: Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minnesota
– sequence: 12
  givenname: Richard J.
  surname: Rodeheffer
  fullname: Rodeheffer, Richard J.
  organization: Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minnesota
– sequence: 13
  givenname: John C.
  surname: Burnett
  fullname: Burnett, John C.
  organization: Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minnesota
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24412355$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21798427$$D View this record in MEDLINE/PubMed
BookMark eNqFkl9v0zAUxSM0xLrBF-ABRUKIp5Z7kzh20DSpqmBMmgCJf4-W4zjUJbGL7UzqE18dp-0YVGJ7urL8O8fX956T5MhYo5LkKcIMActXq9lKSDnLAHEGZBbLg2SChLBpTip6lEyA5mSKUNHj5MT7FQCUDKtHyXGGtGJFRifJr3l6oYwKWqZfhdPChNS2aViqdB7isUvfi1gHtyU-qnXQjdoq0kufzr23UougmvSbDst0IVyjba-CqG038s4GJYO2JtVmazoqXXRd2L4fjA6bx8nDVnRePdnX0-TL2zefF--mVx8uLhfzq6ksCYRpI-qszcqGUUHrlpR5U2Q5EEIBoa5lXTGQeUsrKJq2BsBGEiUxI1AVuWhZnZ8m5zvf9VD3qpHKhNgHXzvdC7fhVmj-743RS_7dXvMcGSOkiAYv9wbO_hyUD7zXXqquE0bZwXNWVVgiZeX9JAMsIM8hks8PyJUdnIlz4EiwYLTEDCP17O_W__R8s8QIvNgDwkvRtU4Yqf0tVxSY5YREju046az3TrVc6iDG9cQf644j8DFXfMXHXPExVxwIjyVKswPpjfudorOdSMXFXmvluJdaGaka7WIseGP13fLzA7nstNHxhz_URvnbUXGfceCfxrSPYcdoSGk1zuX1_w3ue_03_BAOug
CODEN JACCDI
CitedBy_id crossref_primary_10_1016_j_amjcard_2017_06_030
crossref_primary_10_1080_14728222_2016_1254198
crossref_primary_10_1007_s11906_011_0244_5
crossref_primary_10_1161_CIRCULATIONAHA_118_035132
crossref_primary_10_1038_s41598_019_55680_z
crossref_primary_10_1111_ggi_12151
crossref_primary_10_1161_JAHA_119_013966
crossref_primary_10_1007_s42000_020_00222_w
crossref_primary_10_1038_nm_3196
crossref_primary_10_1186_s12933_018_0747_3
crossref_primary_10_1016_j_pharmthera_2014_04_007
crossref_primary_10_3389_fcvm_2022_904881
crossref_primary_10_1016_j_jacbts_2023_08_011
crossref_primary_10_1152_ajpheart_00321_2023
crossref_primary_10_1016_j_molmet_2016_12_010
crossref_primary_10_1097_CRD_0000000000000199
crossref_primary_10_1016_j_medmic_2024_100104
crossref_primary_10_1253_circj_CJ_15_0589
crossref_primary_10_3390_ijms20040798
crossref_primary_10_1007_s12013_014_0086_2
crossref_primary_10_1371_journal_pone_0085708
crossref_primary_10_1093_gerona_glz286
crossref_primary_10_1161_HYPERTENSIONAHA_121_18837
crossref_primary_10_1016_j_medcle_2024_03_025
crossref_primary_10_1039_C6SC05044A
crossref_primary_10_1371_journal_pone_0229280
crossref_primary_10_3390_cells11050766
crossref_primary_10_1016_j_ijcard_2014_07_200
crossref_primary_10_1016_j_mayocp_2018_05_027
crossref_primary_10_1152_ajpregu_00499_2015
crossref_primary_10_1007_s11897_014_0235_3
crossref_primary_10_1536_ihj_13_196
crossref_primary_10_1093_cvr_cvac125
crossref_primary_10_1152_ajpregu_00354_2019
crossref_primary_10_1016_j_medcli_2024_03_028
crossref_primary_10_3389_fphys_2021_815796
crossref_primary_10_1016_j_peptides_2013_07_020
crossref_primary_10_1007_s00018_020_03573_0
crossref_primary_10_1210_jendso_bvaa052
crossref_primary_10_1016_j_jacc_2016_10_001
crossref_primary_10_1016_j_jchf_2020_10_008
crossref_primary_10_1016_j_jacc_2011_12_013
crossref_primary_10_1159_000521295
crossref_primary_10_1097_MOL_0b013e3283521229
crossref_primary_10_1161_HYPERTENSIONAHA_121_17159
crossref_primary_10_1016_j_gene_2015_06_029
crossref_primary_10_1111_dom_15628
crossref_primary_10_3390_diagnostics15010113
crossref_primary_10_1007_s40292_017_0196_1
crossref_primary_10_3390_ijms232214415
crossref_primary_10_3390_ijms24065131
crossref_primary_10_3892_br_2024_1730
crossref_primary_10_1016_j_jacc_2017_11_010
crossref_primary_10_1016_j_jchf_2019_05_012
crossref_primary_10_1111_obr_12598
crossref_primary_10_1186_s12933_024_02475_w
crossref_primary_10_1371_journal_pone_0089201
crossref_primary_10_3390_ijms20133265
crossref_primary_10_1016_j_biochi_2015_05_017
crossref_primary_10_2337_db12_0763
crossref_primary_10_2337_dc20_2107
crossref_primary_10_1016_j_jacc_2015_12_008
crossref_primary_10_1253_circj_CJ_17_0499
crossref_primary_10_1373_clinchem_2012_194167
crossref_primary_10_1093_eurheartj_ehs262
crossref_primary_10_1016_j_ijcard_2014_08_032
crossref_primary_10_1016_j_ijcard_2018_06_002
crossref_primary_10_1016_j_jacbts_2016_10_001
crossref_primary_10_1371_journal_pone_0189858
crossref_primary_10_1093_eurheartj_ehac759
crossref_primary_10_1161_CIRCGENETICS_114_000624
crossref_primary_10_1161_HYPERTENSIONAHA_118_12012
crossref_primary_10_1146_annurev_med_052914_091923
crossref_primary_10_1093_toxsci_kfs273
crossref_primary_10_3945_ajcn_117_157115
crossref_primary_10_1093_ndt_gfu269
crossref_primary_10_1161_HYPERTENSIONAHA_113_01344
crossref_primary_10_1016_j_ddstr_2013_11_002
crossref_primary_10_1161_JAHA_119_012943
crossref_primary_10_1007_s00210_014_0999_8
crossref_primary_10_1186_s13036_017_0093_0
crossref_primary_10_1111_dom_14980
crossref_primary_10_1093_eurheartj_eht466
crossref_primary_10_1186_1471_2350_14_64
crossref_primary_10_2337_dc12_2337
crossref_primary_10_1371_journal_pone_0196869
crossref_primary_10_1042_CS20130427
crossref_primary_10_2337_dc14_0669
crossref_primary_10_2174_1568026619666190826163536
crossref_primary_10_29235_1814_6023_2023_20_2_95_105
Cites_doi 10.1038/nm1137
10.1038/312654a0
10.1016/S0735-1097(02)02059-4
10.1016/S0735-1097(02)02981-9
10.1016/0196-9781(88)90008-3
10.1210/jc.2004-1953
10.3181/0708-RM-216
10.1093/hmg/ddm084
10.1126/science.2935937
10.1016/S0022-2275(20)31162-7
10.1210/jcem-67-3-429
10.1016/j.jacc.2009.02.037
10.1016/S0025-6196(12)61058-1
10.1038/nm724
10.1074/jbc.M303713200
10.1016/0196-9781(96)00152-0
10.2337/db09-0393
10.1001/jama.289.2.194
10.1152/ajpregu.00162.2007
10.1001/archinte.1997.00440420033005
10.1097/00005344-198611000-00005
10.1161/CIRCULATIONAHA.105.538520
10.1073/pnas.102650499
10.1161/01.CIR.37.5.800
10.1161/CIRCULATIONAHA.107.759241
10.1016/j.jacc.2005.09.025
10.1016/j.jacc.2009.02.038
10.1093/hmg/ddp169
10.1038/ng.328
10.1046/j.1523-1755.2000.00411.x
10.1016/0002-9149(87)91133-7
10.1016/j.jacc.2010.01.031
10.1016/j.tem.2006.06.006
10.1016/0024-3205(81)90370-2
10.1161/CIRCULATIONAHA.106.655142
10.1016/0006-291X(84)91077-5
ContentType Journal Article
Copyright 2011 American College of Cardiology Foundation
American College of Cardiology Foundation
2015 INIST-CNRS
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Copyright Elsevier Limited Aug 2, 2011
2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. 2011
Copyright_xml – notice: 2011 American College of Cardiology Foundation
– notice: American College of Cardiology Foundation
– notice: 2015 INIST-CNRS
– notice: Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
– notice: Copyright Elsevier Limited Aug 2, 2011
– notice: 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. 2011
DBID 6I.
AAFTH
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TK
H94
K9.
NAPCQ
7X8
7T2
8FD
C1K
FR3
P64
RC3
5PM
DOI 10.1016/j.jacc.2011.05.011
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Neurosciences Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
Health and Safety Science Abstracts (Full archive)
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Immunology Abstracts
Neurosciences Abstracts
MEDLINE - Academic
Genetics Abstracts
Health & Safety Science Abstracts
Engineering Research Database
Technology Research Database
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList
Genetics Abstracts

AIDS and Cancer Research Abstracts

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1558-3597
EndPage 636
ExternalDocumentID PMC3188554
3272427531
21798427
24412355
10_1016_j_jacc_2011_05_011
S0735109711017797
1_s2_0_S0735109711017797
Genre Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States--US
California
USA, Minnesota
GeographicLocations_xml – name: United States--US
– name: California
– name: USA, Minnesota
GrantInformation_xml – fundername: National Institutes of Health
  grantid: RO1 HL55502; RO1 HL36634; PO1 HL76611
– fundername: NHLBI NIH HHS
  grantid: R01 HL036634
– fundername: NHLBI NIH HHS
  grantid: R01 HL55502
– fundername: NHLBI NIH HHS
  grantid: P01 HL76611
– fundername: NHLBI NIH HHS
  grantid: R01 HL36634
– fundername: NHLBI NIH HHS
  grantid: P01 HL076611
– fundername: NHLBI NIH HHS
  grantid: R01 HL055502
– fundername: National Heart, Lung, and Blood Institute : NHLBI
  grantid: P01 HL076611-06A1 || HL
– fundername: National Heart, Lung, and Blood Institute : NHLBI
  grantid: R01 HL036634-19A1 || HL
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
18M
1B1
1P~
1~.
1~5
2WC
4.4
457
4G.
53G
5GY
5RE
5VS
6PF
7-5
71M
8P~
AABNK
AABVL
AAEDT
AAEDW
AAIKJ
AAOAW
AAQFI
AAXUO
ABBQC
ABFNM
ABFRF
ABLJU
ABMAC
ABOCM
ABWVN
ABXDB
ACGFO
ACGFS
ACIUM
ACJTP
ACPRK
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADVLN
AEFWE
AEKER
AENEX
AEUPX
AEVXI
AEXQZ
AFFNX
AFPUW
AFRAH
AFRHN
AFTJW
AGCQF
AGHFR
AGYEJ
AHMBA
AIGII
AITUG
AJRQY
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BAWUL
BLXMC
CS3
DIK
DU5
E3Z
EBS
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FNPLU
G-Q
GBLVA
GX1
H13
HVGLF
HZ~
IHE
IXB
J1W
K-O
KQ8
L7B
MO0
N9A
O-L
O9-
OA.
OAUVE
OK1
OL~
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SSZ
TR2
UNMZH
UV1
W8F
WH7
WOQ
WOW
YYM
YZZ
Z5R
.55
.GJ
0SF
1CY
29L
3O-
3V.
6I.
7RV
AACTN
AAFTH
AAKUH
AALRI
AAQQT
AAQXK
AAYOK
ABMZM
ABVKL
AFCTW
AFETI
AJOXV
AMFUW
ASPBG
AVWKF
AZFZN
BENPR
BPHCQ
FGOYB
HX~
J5H
N4W
NCXOZ
QTD
R2-
RIG
SEW
T5K
X7M
XPP
YYP
ZGI
ZXP
AAIAV
ABJNI
EFLBG
LCYCR
NAHTW
ZA5
AAYWO
AAYXX
AGQPQ
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TK
H94
K9.
NAPCQ
7X8
7T2
8FD
C1K
FR3
P64
RC3
5PM
ID FETCH-LOGICAL-c650t-dab2f26d87a7bf563d4230557010bbcb980c3f7904dfb001dc5ec1250943af8b3
IEDL.DBID IXB
ISSN 0735-1097
1558-3597
IngestDate Thu Aug 21 14:12:47 EDT 2025
Fri Jul 11 03:45:49 EDT 2025
Thu Jul 10 22:18:05 EDT 2025
Sat Jul 26 03:06:54 EDT 2025
Sat May 31 02:06:16 EDT 2025
Mon Jul 21 09:18:10 EDT 2025
Tue Jul 01 03:41:11 EDT 2025
Thu Apr 24 22:53:57 EDT 2025
Fri Feb 23 02:24:49 EST 2024
Sun Feb 23 10:19:41 EST 2025
Tue Aug 26 16:56:59 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords CRP
SBP
ANP
BNP
lipid metabolism
cGMP
LV
BP
metabolic syndrome
NT-proANP
natriuretic peptides
HDL
NT-proBNP
cardiometabolic disease
SNP
DNA
NPPA
atrial natriuretic peptide
BMI
C-reactive protein
single nucleotide polymorphism
high-density lipoprotein
systolic blood pressure
N-terminal pro-atrial natriuretic peptide
natriuretic peptide precursor A gene
deoxyribonucleic acid
left ventricular
blood pressure
body mass index
B-type natriuretic peptide
3′,5′ cyclic guanosine monophosphate
N-terminal pro–B-type natriuretic peptide
Gene
Genetic variant
Atrial natriuretic peptide
Circulatory system
Cardiology
Protection
Community
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c650t-dab2f26d87a7bf563d4230557010bbcb980c3f7904dfb001dc5ec1250943af8b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0735109711017797
PMID 21798427
PQID 1514876121
PQPubID 2031078
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3188554
proquest_miscellaneous_899161786
proquest_miscellaneous_880140330
proquest_journals_1514876121
pubmed_primary_21798427
pascalfrancis_primary_24412355
crossref_citationtrail_10_1016_j_jacc_2011_05_011
crossref_primary_10_1016_j_jacc_2011_05_011
elsevier_sciencedirect_doi_10_1016_j_jacc_2011_05_011
elsevier_clinicalkeyesjournals_1_s2_0_S0735109711017797
elsevier_clinicalkey_doi_10_1016_j_jacc_2011_05_011
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-08-02
PublicationDateYYYYMMDD 2011-08-02
PublicationDate_xml – month: 08
  year: 2011
  text: 2011-08-02
  day: 02
PublicationDecade 2010
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
– name: New York
PublicationTitle Journal of the American College of Cardiology
PublicationTitleAlternate J Am Coll Cardiol
PublicationYear 2011
Publisher Elsevier Inc
Elsevier
Elsevier Limited
Publisher_xml – name: Elsevier Inc
– name: Elsevier
– name: Elsevier Limited
References Nemer, Chamberland, Sirois (bib5) 1984; 312
Verspohl, Bernemann (bib30) 1996; 17
McKie, Cataliotti, Lahr (bib18) 2010; 55
Shibata, Ouchi, Ito (bib11) 2004; 10
Thibault, Murthy, Gutkowska (bib28) 1988; 9
Cataliotti, Schirger, Martin (bib36) 2005; 112
Wang, Larson, Keyes, Levy, Benjamin, Vasan (bib34) 2007; 115
Miyashita, Itoh, Tsujimoto (bib14) 2009; 58
Redfield, Jacobsen, Burnett, Mahoney, Bailey, Rodeheffer (bib17) 2003; 289
Costello-Boerrigter, Boerrigter, Redfield (bib21) 2006; 47
Shub, Klein, Zachariah, Bailey, Tajik (bib22) 1994; 69
Itoh, Nakao, Sugawara (bib27) 1988; 67
Uehlinger, Weidmann, Gnadinger (bib29) 1986; 8
Sengenes, Bouloumie, Hauner (bib33) 2003; 278
Maeda, Shimomura, Kishida (bib10) 2002; 8
Garbers, Chrisman, Wiegn (bib4) 2006; 17
Costello-Boerrigter, Burnett (bib12) 2009; 53
Levy, Savage, Garrison, Anderson, Kannel, Castelli (bib25) 1987; 59
Murray, Kennedy, Figley (bib23) 1968; 37
Choquet, Cavalcanti-Proenca, Lecoeur (bib16) 2009; 18
Cataliotti, Chen, Schirger (bib35) 2008; 118
Addisu, Gower, Landon, Dietz (bib13) 2008; 233
Pritchett, Jacobsen, Mahoney, Rodeheffer, Bailey, Redfield (bib26) 2003; 41
Galitzky, Sengenes, Thalamas (bib32) 2001; 42
Holtwick, Gotthardt, Skryabin (bib3) 2002; 99
Redfield, Rodeheffer, Jacobsen, Mahoney, Bailey, Burnett (bib24) 2002; 40
Birkenfeld, Boschmann, Moro (bib8) 2005; 90
Moro, Pillard, de Glisezinski (bib31) 2007; 293
Smithies, Kim, Takahashi, Edgell (bib7) 2000; 58
Kangawa, Matsuo (bib2) 1984; 118
(bib19) 1997; 157
de Bold, Borenstein, Veress, Sonnenberg (bib1) 1981; 28
Tsukamoto, Fujita, Kato (bib9) 2009; 53
Meirhaeghe, Sandhu, McCarthy (bib15) 2007; 16
Newton-Cheh, Larson, Vasan (bib6) 2009; 41
Burnett, Kao, Hu (bib20) 1986; 231
Sengenes (10.1016/j.jacc.2011.05.011_bib33) 2003; 278
Smithies (10.1016/j.jacc.2011.05.011_bib7) 2000; 58
Addisu (10.1016/j.jacc.2011.05.011_bib13) 2008; 233
Murray (10.1016/j.jacc.2011.05.011_bib23) 1968; 37
Nemer (10.1016/j.jacc.2011.05.011_bib5) 1984; 312
Redfield (10.1016/j.jacc.2011.05.011_bib24) 2002; 40
Newton-Cheh (10.1016/j.jacc.2011.05.011_bib6) 2009; 41
Moro (10.1016/j.jacc.2011.05.011_bib31) 2007; 293
Maeda (10.1016/j.jacc.2011.05.011_bib10) 2002; 8
Pritchett (10.1016/j.jacc.2011.05.011_bib26) 2003; 41
Costello-Boerrigter (10.1016/j.jacc.2011.05.011_bib21) 2006; 47
Uehlinger (10.1016/j.jacc.2011.05.011_bib29) 1986; 8
McKie (10.1016/j.jacc.2011.05.011_bib18) 2010; 55
Wang (10.1016/j.jacc.2011.05.011_bib34) 2007; 115
Meirhaeghe (10.1016/j.jacc.2011.05.011_bib15) 2007; 16
Choquet (10.1016/j.jacc.2011.05.011_bib16) 2009; 18
Thibault (10.1016/j.jacc.2011.05.011_bib28) 1988; 9
Levy (10.1016/j.jacc.2011.05.011_bib25) 1987; 59
de Bold (10.1016/j.jacc.2011.05.011_bib1) 1981; 28
Itoh (10.1016/j.jacc.2011.05.011_bib27) 1988; 67
Verspohl (10.1016/j.jacc.2011.05.011_bib30) 1996; 17
Costello-Boerrigter (10.1016/j.jacc.2011.05.011_bib12) 2009; 53
Cataliotti (10.1016/j.jacc.2011.05.011_bib35) 2008; 118
Burnett (10.1016/j.jacc.2011.05.011_bib20) 1986; 231
Kangawa (10.1016/j.jacc.2011.05.011_bib2) 1984; 118
(10.1016/j.jacc.2011.05.011_bib19) 1997; 157
Miyashita (10.1016/j.jacc.2011.05.011_bib14) 2009; 58
Shibata (10.1016/j.jacc.2011.05.011_bib11) 2004; 10
Galitzky (10.1016/j.jacc.2011.05.011_bib32) 2001; 42
Holtwick (10.1016/j.jacc.2011.05.011_bib3) 2002; 99
Garbers (10.1016/j.jacc.2011.05.011_bib4) 2006; 17
Tsukamoto (10.1016/j.jacc.2011.05.011_bib9) 2009; 53
Cataliotti (10.1016/j.jacc.2011.05.011_bib36) 2005; 112
Birkenfeld (10.1016/j.jacc.2011.05.011_bib8) 2005; 90
Shub (10.1016/j.jacc.2011.05.011_bib22) 1994; 69
Redfield (10.1016/j.jacc.2011.05.011_bib17) 2003; 289
References_xml – volume: 40
  start-page: 976
  year: 2002
  end-page: 982
  ident: bib24
  article-title: Plasma brain natriuretic peptide concentration: impact of age and gender
  publication-title: J Am Coll Cardiol
– volume: 233
  start-page: 475
  year: 2008
  end-page: 482
  ident: bib13
  article-title: B-type natriuretic peptide decreases gastric emptying and absorption
  publication-title: Exp Biol Med (Maywood)
– volume: 59
  start-page: 956
  year: 1987
  end-page: 960
  ident: bib25
  article-title: Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study
  publication-title: Am J Cardiol
– volume: 112
  start-page: 836
  year: 2005
  end-page: 840
  ident: bib36
  article-title: Oral human brain natriuretic peptide activates cyclic guanosine 3′,5′-monophosphate and decreases mean arterial pressure
  publication-title: Circulation
– volume: 41
  start-page: 1036
  year: 2003
  end-page: 1043
  ident: bib26
  article-title: Left atrial volume as an index of left atrial size: a population-based study
  publication-title: J Am Coll Cardiol
– volume: 115
  start-page: 1345
  year: 2007
  end-page: 1353
  ident: bib34
  article-title: Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals
  publication-title: Circulation
– volume: 118
  start-page: 1729
  year: 2008
  end-page: 1736
  ident: bib35
  article-title: Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertension
  publication-title: Circulation
– volume: 67
  start-page: 429
  year: 1988
  end-page: 437
  ident: bib27
  article-title: Gamma-atrial natriuretic polypeptide (gamma ANP)-derived peptides in human plasma: cosecretion of N-terminal gamma ANP fragment and alpha ANP
  publication-title: J Clin Endocrinol Metab
– volume: 312
  start-page: 654
  year: 1984
  end-page: 656
  ident: bib5
  article-title: Gene structure of human cardiac hormone precursor, pronatriodilatin
  publication-title: Nature
– volume: 16
  start-page: 1343
  year: 2007
  end-page: 1350
  ident: bib15
  article-title: Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations
  publication-title: Hum Mol Genet
– volume: 289
  start-page: 194
  year: 2003
  end-page: 202
  ident: bib17
  article-title: Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic
  publication-title: JAMA
– volume: 37
  start-page: 800
  year: 1968
  end-page: 804
  ident: bib23
  article-title: Quantitative angiocardiography
  publication-title: Circulation
– volume: 118
  start-page: 131
  year: 1984
  end-page: 139
  ident: bib2
  article-title: Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP)
  publication-title: Biochem Biophys Res Commun
– volume: 293
  start-page: R612
  year: 2007
  end-page: R617
  ident: bib31
  article-title: Atrial natriuretic peptide contribution to lipid mobilization and utilization during head-down bed rest in humans
  publication-title: Am J Physiol Regul Integr Comp Physiol
– volume: 157
  start-page: 2413
  year: 1997
  end-page: 2446
  ident: bib19
  article-title: The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
  publication-title: Arch Intern Med
– volume: 47
  start-page: 345
  year: 2006
  end-page: 353
  ident: bib21
  article-title: Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction
  publication-title: J Am Coll Cardiol
– volume: 41
  start-page: 348
  year: 2009
  end-page: 353
  ident: bib6
  article-title: Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure
  publication-title: Nat Genet
– volume: 28
  start-page: 89
  year: 1981
  end-page: 94
  ident: bib1
  article-title: A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
  publication-title: Life Sci
– volume: 55
  start-page: 2140
  year: 2010
  end-page: 2147
  ident: bib18
  article-title: The prognostic value of N-terminal pro–B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects
  publication-title: J Am Coll Cardiol
– volume: 17
  start-page: 1023
  year: 1996
  end-page: 1029
  ident: bib30
  article-title: Atrial natriuretic peptide (ANP)-induced inhibition of glucagon secretion: mechanism of action in isolated rat pancreatic islets
  publication-title: Peptides
– volume: 53
  start-page: 2078
  year: 2009
  end-page: 2079
  ident: bib12
  article-title: A new role for the natriuretic peptides: metabolic regulators of the adipocyte
  publication-title: J Am Coll Cardiol
– volume: 17
  start-page: 251
  year: 2006
  end-page: 258
  ident: bib4
  article-title: Membrane guanylyl cyclase receptors: an update
  publication-title: Trends Endocrinol Metab
– volume: 53
  start-page: 2070
  year: 2009
  end-page: 2077
  ident: bib9
  article-title: Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure
  publication-title: J Am Coll Cardiol
– volume: 10
  start-page: 1384
  year: 2004
  end-page: 1389
  ident: bib11
  article-title: Adiponectin-mediated modulation of hypertrophic signals in the heart
  publication-title: Nat Med
– volume: 18
  start-page: 2495
  year: 2009
  end-page: 2501
  ident: bib16
  article-title: The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects
  publication-title: Hum Mol Genet
– volume: 99
  start-page: 7142
  year: 2002
  end-page: 7147
  ident: bib3
  article-title: Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure
  publication-title: Proc Natl Acad Sci U S A
– volume: 69
  start-page: 205
  year: 1994
  end-page: 211
  ident: bib22
  article-title: Determination of left ventricular mass by echocardiography in a normal population: effect of age and sex in addition to body size
  publication-title: Mayo Clin Proc
– volume: 9
  start-page: 47
  year: 1988
  end-page: 53
  ident: bib28
  article-title: NH2-terminal fragment of rat pro-atrial natriuretic factor in the circulation: identification, radioimmunoassay and half-life
  publication-title: Peptides
– volume: 8
  start-page: 731
  year: 2002
  end-page: 737
  ident: bib10
  article-title: Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
  publication-title: Nat Med
– volume: 231
  start-page: 1145
  year: 1986
  end-page: 1147
  ident: bib20
  article-title: Atrial natriuretic peptide elevation in congestive heart failure in the human
  publication-title: Science
– volume: 8
  start-page: 1122
  year: 1986
  end-page: 1129
  ident: bib29
  article-title: Increase in circulating insulin induced by atrial natriuretic peptide in normal humans
  publication-title: J Cardiovasc Pharmacol
– volume: 58
  start-page: 2265
  year: 2000
  end-page: 2280
  ident: bib7
  article-title: Importance of quantitative genetic variations in the etiology of hypertension
  publication-title: Kidney Int
– volume: 42
  start-page: 536
  year: 2001
  end-page: 544
  ident: bib32
  article-title: The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men
  publication-title: J Lipid Res
– volume: 90
  start-page: 3622
  year: 2005
  end-page: 3628
  ident: bib8
  article-title: Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans
  publication-title: J Clin Endocrinol Metab
– volume: 58
  start-page: 2880
  year: 2009
  end-page: 2892
  ident: bib14
  article-title: Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity
  publication-title: Diabetes
– volume: 278
  start-page: 48617
  year: 2003
  end-page: 48626
  ident: bib33
  article-title: Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes
  publication-title: J Biol Chem
– volume: 10
  start-page: 1384
  year: 2004
  ident: 10.1016/j.jacc.2011.05.011_bib11
  article-title: Adiponectin-mediated modulation of hypertrophic signals in the heart
  publication-title: Nat Med
  doi: 10.1038/nm1137
– volume: 312
  start-page: 654
  year: 1984
  ident: 10.1016/j.jacc.2011.05.011_bib5
  article-title: Gene structure of human cardiac hormone precursor, pronatriodilatin
  publication-title: Nature
  doi: 10.1038/312654a0
– volume: 40
  start-page: 976
  year: 2002
  ident: 10.1016/j.jacc.2011.05.011_bib24
  article-title: Plasma brain natriuretic peptide concentration: impact of age and gender
  publication-title: J Am Coll Cardiol
  doi: 10.1016/S0735-1097(02)02059-4
– volume: 41
  start-page: 1036
  year: 2003
  ident: 10.1016/j.jacc.2011.05.011_bib26
  article-title: Left atrial volume as an index of left atrial size: a population-based study
  publication-title: J Am Coll Cardiol
  doi: 10.1016/S0735-1097(02)02981-9
– volume: 9
  start-page: 47
  year: 1988
  ident: 10.1016/j.jacc.2011.05.011_bib28
  article-title: NH2-terminal fragment of rat pro-atrial natriuretic factor in the circulation: identification, radioimmunoassay and half-life
  publication-title: Peptides
  doi: 10.1016/0196-9781(88)90008-3
– volume: 90
  start-page: 3622
  year: 2005
  ident: 10.1016/j.jacc.2011.05.011_bib8
  article-title: Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2004-1953
– volume: 233
  start-page: 475
  year: 2008
  ident: 10.1016/j.jacc.2011.05.011_bib13
  article-title: B-type natriuretic peptide decreases gastric emptying and absorption
  publication-title: Exp Biol Med (Maywood)
  doi: 10.3181/0708-RM-216
– volume: 16
  start-page: 1343
  year: 2007
  ident: 10.1016/j.jacc.2011.05.011_bib15
  article-title: Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddm084
– volume: 231
  start-page: 1145
  year: 1986
  ident: 10.1016/j.jacc.2011.05.011_bib20
  article-title: Atrial natriuretic peptide elevation in congestive heart failure in the human
  publication-title: Science
  doi: 10.1126/science.2935937
– volume: 42
  start-page: 536
  year: 2001
  ident: 10.1016/j.jacc.2011.05.011_bib32
  article-title: The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men
  publication-title: J Lipid Res
  doi: 10.1016/S0022-2275(20)31162-7
– volume: 67
  start-page: 429
  year: 1988
  ident: 10.1016/j.jacc.2011.05.011_bib27
  article-title: Gamma-atrial natriuretic polypeptide (gamma ANP)-derived peptides in human plasma: cosecretion of N-terminal gamma ANP fragment and alpha ANP
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem-67-3-429
– volume: 53
  start-page: 2078
  year: 2009
  ident: 10.1016/j.jacc.2011.05.011_bib12
  article-title: A new role for the natriuretic peptides: metabolic regulators of the adipocyte
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2009.02.037
– volume: 69
  start-page: 205
  year: 1994
  ident: 10.1016/j.jacc.2011.05.011_bib22
  article-title: Determination of left ventricular mass by echocardiography in a normal population: effect of age and sex in addition to body size
  publication-title: Mayo Clin Proc
  doi: 10.1016/S0025-6196(12)61058-1
– volume: 8
  start-page: 731
  year: 2002
  ident: 10.1016/j.jacc.2011.05.011_bib10
  article-title: Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
  publication-title: Nat Med
  doi: 10.1038/nm724
– volume: 278
  start-page: 48617
  year: 2003
  ident: 10.1016/j.jacc.2011.05.011_bib33
  article-title: Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M303713200
– volume: 17
  start-page: 1023
  year: 1996
  ident: 10.1016/j.jacc.2011.05.011_bib30
  article-title: Atrial natriuretic peptide (ANP)-induced inhibition of glucagon secretion: mechanism of action in isolated rat pancreatic islets
  publication-title: Peptides
  doi: 10.1016/0196-9781(96)00152-0
– volume: 58
  start-page: 2880
  year: 2009
  ident: 10.1016/j.jacc.2011.05.011_bib14
  article-title: Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity
  publication-title: Diabetes
  doi: 10.2337/db09-0393
– volume: 289
  start-page: 194
  year: 2003
  ident: 10.1016/j.jacc.2011.05.011_bib17
  article-title: Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic
  publication-title: JAMA
  doi: 10.1001/jama.289.2.194
– volume: 293
  start-page: R612
  year: 2007
  ident: 10.1016/j.jacc.2011.05.011_bib31
  article-title: Atrial natriuretic peptide contribution to lipid mobilization and utilization during head-down bed rest in humans
  publication-title: Am J Physiol Regul Integr Comp Physiol
  doi: 10.1152/ajpregu.00162.2007
– volume: 157
  start-page: 2413
  year: 1997
  ident: 10.1016/j.jacc.2011.05.011_bib19
  article-title: The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.1997.00440420033005
– volume: 8
  start-page: 1122
  year: 1986
  ident: 10.1016/j.jacc.2011.05.011_bib29
  article-title: Increase in circulating insulin induced by atrial natriuretic peptide in normal humans
  publication-title: J Cardiovasc Pharmacol
  doi: 10.1097/00005344-198611000-00005
– volume: 112
  start-page: 836
  year: 2005
  ident: 10.1016/j.jacc.2011.05.011_bib36
  article-title: Oral human brain natriuretic peptide activates cyclic guanosine 3′,5′-monophosphate and decreases mean arterial pressure
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.105.538520
– volume: 99
  start-page: 7142
  year: 2002
  ident: 10.1016/j.jacc.2011.05.011_bib3
  article-title: Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.102650499
– volume: 37
  start-page: 800
  year: 1968
  ident: 10.1016/j.jacc.2011.05.011_bib23
  article-title: Quantitative angiocardiography
  publication-title: Circulation
  doi: 10.1161/01.CIR.37.5.800
– volume: 118
  start-page: 1729
  year: 2008
  ident: 10.1016/j.jacc.2011.05.011_bib35
  article-title: Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertension
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.107.759241
– volume: 47
  start-page: 345
  year: 2006
  ident: 10.1016/j.jacc.2011.05.011_bib21
  article-title: Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2005.09.025
– volume: 53
  start-page: 2070
  year: 2009
  ident: 10.1016/j.jacc.2011.05.011_bib9
  article-title: Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2009.02.038
– volume: 18
  start-page: 2495
  year: 2009
  ident: 10.1016/j.jacc.2011.05.011_bib16
  article-title: The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddp169
– volume: 41
  start-page: 348
  year: 2009
  ident: 10.1016/j.jacc.2011.05.011_bib6
  article-title: Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure
  publication-title: Nat Genet
  doi: 10.1038/ng.328
– volume: 58
  start-page: 2265
  year: 2000
  ident: 10.1016/j.jacc.2011.05.011_bib7
  article-title: Importance of quantitative genetic variations in the etiology of hypertension
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.2000.00411.x
– volume: 59
  start-page: 956
  year: 1987
  ident: 10.1016/j.jacc.2011.05.011_bib25
  article-title: Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study
  publication-title: Am J Cardiol
  doi: 10.1016/0002-9149(87)91133-7
– volume: 55
  start-page: 2140
  year: 2010
  ident: 10.1016/j.jacc.2011.05.011_bib18
  article-title: The prognostic value of N-terminal pro–B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2010.01.031
– volume: 17
  start-page: 251
  year: 2006
  ident: 10.1016/j.jacc.2011.05.011_bib4
  article-title: Membrane guanylyl cyclase receptors: an update
  publication-title: Trends Endocrinol Metab
  doi: 10.1016/j.tem.2006.06.006
– volume: 28
  start-page: 89
  year: 1981
  ident: 10.1016/j.jacc.2011.05.011_bib1
  article-title: A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
  publication-title: Life Sci
  doi: 10.1016/0024-3205(81)90370-2
– volume: 115
  start-page: 1345
  year: 2007
  ident: 10.1016/j.jacc.2011.05.011_bib34
  article-title: Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.106.655142
– volume: 118
  start-page: 131
  year: 1984
  ident: 10.1016/j.jacc.2011.05.011_bib2
  article-title: Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP)
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/0006-291X(84)91077-5
SSID ssj0006819
Score 2.3585584
Snippet We sought to define the cardiometabolic phenotype associated with rs5068, a genetic variant of the atrial natriuretic peptide (ANP) gene. The ANP and B-type...
Objectives We sought to define the cardiometabolic phenotype associated with rs5068, a genetic variant of the atrial natriuretic peptide (ANP) gene. Background...
We sought to define the cardiometabolic phenotype associated with rs5068, a genetic variant of the atrial natriuretic peptide (ANP) gene.OBJECTIVESWe sought to...
OBJECTIVES: We sought to define the cardiometabolic phenotype associated with rs5068, a genetic variant of the atrial natriuretic peptide (ANP) gene....
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 629
SubjectTerms Age
Aged
Alleles
Atrial Natriuretic Factor - genetics
atrial natriuretic peptide
Biological and medical sciences
Blood Pressure
body mass
Body Mass Index
Cardiology
Cardiology. Vascular system
cardiometabolic disease
Cardiovascular
Cardiovascular disease
Cholesterol
Deoxyribonucleic acid
Diabetes
DNA
DNA - metabolism
Echocardiography, Doppler - methods
Female
Genetic Variation
Genotype
Genotype & phenotype
Genotypes
Glucose
Heart attacks
Heart failure
Homeostasis
Humans
Hypertension
Internal Medicine
Kinases
lipid metabolism
Lipoproteins
Male
Medical sciences
metabolic disorders
metabolic syndrome
Middle Aged
myocardial infarction
Natriuretic Peptide, Brain - genetics
natriuretic peptides
obesity
Peptides
Phenotype
Population
Protein Structure, Tertiary
Proteins
Random Allocation
Rodents
Software
Studies
Title A Genetic Variant of the Atrial Natriuretic Peptide Gene Is Associated With Cardiometabolic Protection in the General Community
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0735109711017797
https://www.clinicalkey.es/playcontent/1-s2.0-S0735109711017797
https://dx.doi.org/10.1016/j.jacc.2011.05.011
https://www.ncbi.nlm.nih.gov/pubmed/21798427
https://www.proquest.com/docview/1514876121
https://www.proquest.com/docview/880140330
https://www.proquest.com/docview/899161786
https://pubmed.ncbi.nlm.nih.gov/PMC3188554
Volume 58
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGHhASQnyTMSo_8IZCHbtJnMdSMQ2kTUgw6JsVf0TLNNKKpA97gX-dO8fJKIwi8dSqvktq-3L3c3z3MyEvc5tpbQsWc8dLWKCYPC7LLINvumCpdLxiWI18cpodn83eL9PlHlkMtTCYVhl8f-_TvbcOv0zDaE7XdT39CMaZ4v5pglaVF1hRLmbSF_Et34zeOJP-cA8UjlE6FM70OV4XpTGBxhPZO5O_Bae767KFIav6sy5uAqO_51T-EqSO7pN7AV3Sed-BB2TPNQ_J7ZOwf_6I_JhT5JmGVvoZFskwqnRVUcCAdO6P76CnyNi_8ZWN9AMmvFjnNei7lg4z6Sz9UnfndOFTWb-6DuzoEuV7ygeYaFo3_qKB05qGKpTu6jE5O3r7aXEchyMYYgPQrYttqXnFMyvzMtdVmgkL8MvTdiVMa6MLyYyo8oLNbIX4y5rUGcBMmK9YVlKLJ2S_WTXuGaFwGSaMSEsNqC0zRla2sLyQFlZo4K1FRJJh7JUJ_OR4TMalGhLRLhTOl8L5UixV8BGRV6POumfn2CkthilVQ90peEoFwWOnVn6TlmvDw96qRLVcMfWHQUYkHTW3bPqfd5xs2dvYNYBiWNqcRuRwMEB1_S8A-kJoSzjo07EZnAXuAJWNW21aJZEriAnBdojggiHJZRaRp71FX98eye1mHPqVb9n6KIBU5dstTX3uKcshcmA-5MF_jshzcmd4l8_4Idnvvm3cCwCDnZ6QW6-_JxP_zP8EJ_1eCQ
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGkAAJIb5XGMMPvKGojtM4yWOpmFpYKyQ26JsVf0TLNNJqSR944l_nznEyCqNIPLWq75Lavtz9HN_9TMibxAilTMYCbnkOCxSdBHkuBHxTGYtTywuG1cjzhZiejT4s4-UemXS1MJhW6X1_69Odt_a_DP1oDtdlOfwMxhnj_mmIVpVkyS1yG9CAQNOeLd_17lik7nQPlA5Q3FfOtEleF7nWnscT6TvDv0Wn--u8hjEr2sMubkKjvydV_hKljh-SBx5e0nHbg0dkz1aPyZ2530B_Qn6MKRJNQyv9AqtkGFa6KiiAQDp253fQBVL2b1xpI_2EGS_GOg06q2k3ldbQr2VzTicul_WbbcCQLlG-5XyAmaZl5S7qSa2pL0Npvj8lZ8fvTyfTwJ_BEGjAbk1gcsULLkya5IkqYhEZwF-OtytkSmmVpUxHRZKxkSkQgBkdWw2gCRMW8yJV0TOyX60qe0AoXIZFOopzBbBNaJ0WJjM8Sw0s0cBdRwMSdmMvtScox3MyLmWXiXYhcb4kzpdksYSPAXnb66xbeo6d0lE3pbIrPAVXKSF67NRKbtKytX_aaxnKmksm_7DIAYl7zS2j_ucdj7bsre8aYDGsbY4H5LAzQHn9LwD7QmwLOejTvhm8BW4B5ZVdbWqZIlkQiyK2QwRXDGGSigF53lr09e2R3W7EoV_Jlq33AshVvt1SleeOsxxCByZEvvjPEXlN7k5P5yfyZLb4-JLc617sM35I9purjX0FyLBRR-7J_wmNHWAy
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Genetic+Variant+of+the+Atrial+Natriuretic+Peptide+Gene+Is+Associated+With+Cardiometabolic+Protection+in+the+General+Community&rft.jtitle=Journal+of+the+American+College+of+Cardiology&rft.au=Cannone%2C+Valentina%2C+MD%2C+PhD&rft.au=Boerrigter%2C+Guido%2C+MD&rft.au=Cataliotti%2C+Alessandro%2C+MD%2C+PhD&rft.au=Costello-Boerrigter%2C+Lisa+C.%2C+MD%2C+PhD&rft.date=2011-08-02&rft.issn=0735-1097&rft.volume=58&rft.issue=6&rft.spage=629&rft.epage=636&rft_id=info:doi/10.1016%2Fj.jacc.2011.05.011&rft.externalDBID=ECK1-s2.0-S0735109711017797&rft.externalDocID=1_s2_0_S0735109711017797
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F07351097%2FS0735109711X0027X%2Fcov150h.gif